HYDROXYZINE RENAUDIN 100 mg/2 ml, solution for injection 10 ampoules of 2 ml
Active ingredients: Hydroxyzine monohydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HYDROXYZINE RENAUDIN 100 mg/2 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- LABORATOIRE RENAUDIN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Feb 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescription valid for up to 12 weeks
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63999867CIP73613565CIP133400936135659Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'HYDROXYZINEsolution | 100 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.